Clinical Trial

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-07-29; most recent amendment 2025-09-30.
Status change: Not Yet Recruiting → Recruiting 2022-03-03
Trial Details
NCT Number NCT04983823
Lead Sponsor Baker Heart and Diabetes Institute
Conditions Heart Failure
Enrollment 820 participants
Start Date 2021-11-18
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-03